120 related articles for article (PubMed ID: 38096674)
1. Association between adherence to posttreatment National Comprehensive Cancer Network (NCCN) surveillance guidelines and detection of recurrent uterine cancer.
Mayer CM; O'Connor RM; Do AT; Cerda VR; Wang SM; Scott ME; Li AJ; Rimel BJ; Manuel MR; Taylor KN; Kim KH
Gynecol Oncol; 2024 Feb; 181():8-11. PubMed ID: 38096674
[TBL] [Abstract][Full Text] [Related]
2. Association of NCCN-Recommended Posttreatment Surveillance With Outcomes in Patients With HPV-Associated Oropharyngeal Squamous Cell Carcinoma.
Masroor F; Corpman D; Carpenter DM; Ritterman Weintraub M; Cheung KHN; Wang KH
JAMA Otolaryngol Head Neck Surg; 2019 Oct; 145(10):903-908. PubMed ID: 31393552
[TBL] [Abstract][Full Text] [Related]
3. Adherence patterns to National Comprehensive Cancer Network (NCCN) guidelines for referral to cancer genetic professionals.
Febbraro T; Robison K; Wilbur JS; Laprise J; Bregar A; Lopes V; Legare R; Stuckey A
Gynecol Oncol; 2015 Jul; 138(1):109-14. PubMed ID: 25933682
[TBL] [Abstract][Full Text] [Related]
4. Value of Adherence to Posttreatment Follow-Up Guidelines for Head and Neck Squamous Cell Carcinoma.
Stone A; Liu J; Lin J; Schiff BA; Ow TJ; Mehta V; Smith RV
Laryngoscope; 2024 Feb; 134(2):708-716. PubMed ID: 37493178
[TBL] [Abstract][Full Text] [Related]
5. Clinical Impact of Adherence to NCCN Guidelines for Biomarker Testing and First-Line Treatment in Advanced Non-Small Cell Lung Cancer (aNSCLC) Using Real-World Electronic Health Record Data.
John A; Yang B; Shah R
Adv Ther; 2021 Mar; 38(3):1552-1566. PubMed ID: 33537872
[TBL] [Abstract][Full Text] [Related]
6. Gynecologic cancer in HIV-infected women: treatment and outcomes in a multi-institutional cohort.
Levinson KL; Riedel DJ; Ojalvo LS; Chan W; Angarita AM; Fader AN; Rositch AF
AIDS; 2018 Jan; 32(2):171-177. PubMed ID: 29028665
[TBL] [Abstract][Full Text] [Related]
7. Adherence to surveillance guidelines after radical cystectomy: a population-based analysis.
Ehdaie B; Atoria CL; Lowrance WT; Herr HW; Bochner BH; Donat SM; Dalbagni G; Elkin EB
Urol Oncol; 2014 Aug; 32(6):779-84. PubMed ID: 24935876
[TBL] [Abstract][Full Text] [Related]
8. Socioeconomic status as a predictor of adherence to treatment guidelines for early-stage ovarian cancer.
Hodeib M; Chang J; Liu F; Ziogas A; Dilley S; Randall LM; Anton-Culver H; Bristow RE
Gynecol Oncol; 2015 Jul; 138(1):121-7. PubMed ID: 25913132
[TBL] [Abstract][Full Text] [Related]
9. Uterine Neoplasms, Version 1.2018, NCCN Clinical Practice Guidelines in Oncology.
Koh WJ; Abu-Rustum NR; Bean S; Bradley K; Campos SM; Cho KR; Chon HS; Chu C; Cohn D; Crispens MA; Damast S; Dorigo O; Eifel PJ; Fisher CM; Frederick P; Gaffney DK; George S; Han E; Higgins S; Huh WK; Lurain JR; Mariani A; Mutch D; Nagel C; Nekhlyudov L; Fader AN; Remmenga SW; Reynolds RK; Tillmanns T; Ueda S; Wyse E; Yashar CM; McMillian NR; Scavone JL
J Natl Compr Canc Netw; 2018 Feb; 16(2):170-199. PubMed ID: 29439178
[TBL] [Abstract][Full Text] [Related]
10. NCCN Guidelines® Insights: Uterine Neoplasms, Version 3.2021.
Abu-Rustum NR; Yashar CM; Bradley K; Campos SM; Chino J; Chon HS; Chu C; Cohn D; Crispens MA; Damast S; Diver E; Fisher CM; Frederick P; Gaffney DK; George S; Giuntoli R; Han E; Howitt B; Huh WK; Lea J; Mariani A; Mutch D; Nekhlyudov L; Podoll M; Remmenga SW; Reynolds RK; Salani R; Sisodia R; Soliman P; Tanner E; Ueda S; Urban R; Wethington SL; Wyse E; Zanotti K; McMillian NR; Motter AD
J Natl Compr Canc Netw; 2021 Aug; 19(8):888-895. PubMed ID: 34416706
[TBL] [Abstract][Full Text] [Related]
11. Reasons for failure to deliver National Comprehensive Cancer Network (NCCN)-adherent care in the treatment of epithelial ovarian cancer at an NCCN cancer center.
Erickson BK; Martin JY; Shah MM; Straughn JM; Leath CA
Gynecol Oncol; 2014 May; 133(2):142-6. PubMed ID: 24517876
[TBL] [Abstract][Full Text] [Related]
12. Guideline - Adherence in advanced stage head and neck cancer is associated with improved survival - A National study.
Cohen O; Brauer PR; Judson BL; Burtness BA; Earles J; Mehra S
Oral Oncol; 2022 Feb; 125():105694. PubMed ID: 34971883
[TBL] [Abstract][Full Text] [Related]
13. Uterine Neoplasms, Version 1.2023, NCCN Clinical Practice Guidelines in Oncology.
Abu-Rustum N; Yashar C; Arend R; Barber E; Bradley K; Brooks R; Campos SM; Chino J; Chon HS; Chu C; Crispens MA; Damast S; Fisher CM; Frederick P; Gaffney DK; Giuntoli R; Han E; Holmes J; Howitt BE; Lea J; Mariani A; Mutch D; Nagel C; Nekhlyudov L; Podoll M; Salani R; Schorge J; Siedel J; Sisodia R; Soliman P; Ueda S; Urban R; Wethington SL; Wyse E; Zanotti K; McMillian NR; Aggarwal S
J Natl Compr Canc Netw; 2023 Feb; 21(2):181-209. PubMed ID: 36791750
[TBL] [Abstract][Full Text] [Related]
14. Guideline-adherent treatment, sociodemographic disparities, and cause-specific survival for endometrial carcinomas.
Rodriguez VE; LeBrón AMW; Chang J; Bristow RE
Cancer; 2021 Jul; 127(14):2423-2431. PubMed ID: 33721357
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of the cost of CA-125 measurement, physical exam, and imaging in the diagnosis of recurrent ovarian cancer.
Armstrong A; Otvos B; Singh S; Debernardo R
Gynecol Oncol; 2013 Dec; 131(3):503-7. PubMed ID: 24060416
[TBL] [Abstract][Full Text] [Related]
16. Improving NCCN guideline-adherent care for ovarian cancer: Value of an intervention.
Dottino JA; Cliby WA; Myers ER; Bristow RE; Havrilesky LJ
Gynecol Oncol; 2015 Sep; 138(3):694-9. PubMed ID: 26072441
[TBL] [Abstract][Full Text] [Related]
17. Adherence to National Comprehensive Cancer Network Guidelines is Associated with Improved Survival for Patients with Stage 2A and Stages 2B and 3 Extremity and Superficial Trunk Soft Tissue Sarcoma.
Voss RK; Chiang YJ; Torres KE; Guadagnolo BA; Mann GN; Feig BW; Cormier JN; Roland CL
Ann Surg Oncol; 2017 Oct; 24(11):3271-3278. PubMed ID: 28741122
[TBL] [Abstract][Full Text] [Related]
18. Uterine Sarcoma, Version 1.2016: Featured Updates to the NCCN Guidelines.
Koh WJ; Greer BE; Abu-Rustum NR; Apte SM; Campos SM; Cho KR; Chu C; Cohn D; Crispens MA; Dizon DS; Dorigo O; Eifel PJ; Fisher CM; Frederick P; Gaffney DK; George S; Han E; Higgins S; Huh WK; Lurain JR; Mariani A; Mutch D; Fader AN; Remmenga SW; Reynolds RK; Tillmanns T; Valea FA; Yashar CM; McMillian NR; Scavone JL;
J Natl Compr Canc Netw; 2015 Nov; 13(11):1321-31. PubMed ID: 26553763
[TBL] [Abstract][Full Text] [Related]
19. Does adherence to National Comprehensive Cancer Network guidelines improve pain-related outcomes? An evaluation of inpatient cancer pain management at an academic medical center.
Mearis M; Shega JW; Knoebel RW
J Pain Symptom Manage; 2014 Sep; 48(3):451-8. PubMed ID: 24439844
[TBL] [Abstract][Full Text] [Related]
20. Spatial analysis of adherence to treatment guidelines for advanced-stage ovarian cancer and the impact of race and socioeconomic status.
Bristow RE; Chang J; Ziogas A; Anton-Culver H; Vieira VM
Gynecol Oncol; 2014 Jul; 134(1):60-7. PubMed ID: 24680770
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
